Norman R. Hames Sells 5,000 Shares of RadNet Inc. (RDNT) Stock
RadNet Inc. (NASDAQ:RDNT) insider Norman R. Hames sold 5,000 shares of the firm’s stock in a transaction on Wednesday, December 6th. The stock was sold at an average price of $9.72, for a total value of $48,600.00. Following the completion of the transaction, the insider now owns 402,587 shares in the company, valued at $3,913,145.64. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
RadNet Inc. (RDNT) traded down $0.10 during trading hours on Friday, hitting $9.65. The stock had a trading volume of 172,539 shares, compared to its average volume of 243,234. The company has a market cap of $464.33, a price-to-earnings ratio of 32.50, a P/E/G ratio of 3.28 and a beta of 0.82. RadNet Inc. has a 1-year low of $5.25 and a 1-year high of $11.90. The company has a debt-to-equity ratio of 7.88, a current ratio of 1.29 and a quick ratio of 1.29.
RadNet (NASDAQ:RDNT) last issued its quarterly earnings data on Thursday, November 9th. The medical research company reported $0.12 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.12. The business had revenue of $227.60 million for the quarter, compared to the consensus estimate of $232.84 million. RadNet had a return on equity of 23.73% and a net margin of 1.21%. The firm’s revenue was up 1.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.11 EPS. sell-side analysts predict that RadNet Inc. will post 0.35 earnings per share for the current year.
Institutional investors have recently modified their holdings of the stock. Airain ltd acquired a new stake in RadNet during the 2nd quarter worth $100,000. National Planning Corp raised its stake in RadNet by 9.8% during the 2nd quarter. National Planning Corp now owns 16,796 shares of the medical research company’s stock worth $132,000 after buying an additional 1,500 shares during the period. Cubist Systematic Strategies LLC acquired a new stake in RadNet during the 3rd quarter worth $195,000. Prudential Financial Inc. raised its stake in RadNet by 15.2% during the 2nd quarter. Prudential Financial Inc. now owns 20,410 shares of the medical research company’s stock worth $158,000 after buying an additional 2,700 shares during the period. Finally, Parallax Volatility Advisers L.P. raised its stake in RadNet by 122.0% during the 2nd quarter. Parallax Volatility Advisers L.P. now owns 21,122 shares of the medical research company’s stock worth $164,000 after buying an additional 117,148 shares during the period. 53.24% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “Norman R. Hames Sells 5,000 Shares of RadNet Inc. (RDNT) Stock” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/12/09/norman-r-hames-sells-5000-shares-of-radnet-inc-rdnt-stock.html.
RadNet Company Profile
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Stock Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related stocks with our FREE daily email newsletter.